Introducing GS1 standards to the clinical trial supply chain at Creapharm, a Myonex company
In the clinical trial industry, drug identification and traceability are essential to ensuring patient safety.
Body
However, up until recently, most stakeholders used their own internal tools and proprietary identifiers for tracing investigational products and their locations, as well as for data interchange in clinical trials.
As a result, participants had to configure their IT systems to adapt to each solution implemented by each specific Investigational Medicinal Product (IMP) manufacturer.
File
